SCHEMBL17599400

SCHEMBL17599400

O=C(O)c1cccc(-c2ccc(NS(=O)(=O)c3c(F)cccc3F)c3ccccc23)c1

nearest known ligand 0.49

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 1/20 0.49
KAT6A Q92794 2/20 0.46
BRD4 O60885 1/20 0.45
FABP4 P15090 2/20 0.44
FABP5 Q01469 1/20 0.44
ACLY P53396 5/20 0.43
AKR1C3 P42330 1/20 0.43
AKR1C2 P52895 1/20 0.43
MCL1 Q07820 2/20 0.42
SLC16A3 O15427 1/20 0.42
PTK2B Q14289 2/20 0.42
SMN1; SMN2 Q16637 1/20 0.42
MAOA P21397 1/20 0.42
BLVRB P30043 1/20 0.42
HDAC6 Q9UBN7 1/20 0.42
KDM4E B2RXH2 1/20 0.42
TSHR P16473 1/20 0.42
PFKFB3 Q16875 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17599329 0.84 KMT2A (0.55) KMT2ABRD4FABP4ACLYAKR1C3
SCHEMBL17599342 0.84 FABP4 (0.45) KMT2AFABP4FABP5ACLYSLC16A3
SCHEMBL17599310 0.83 PTK2B (0.53) KMT2AFABP4FABP5ACLYPTK2B
SCHEMBL17599337 0.83 PTK2B (0.50) KMT2AFABP4FABP5ACLYSLC16A3
SCHEMBL17599303 0.82 MCL1 (0.45) KMT2AACLYMCL1PTK2BKDM4E
SCHEMBL17599368 0.81 KDM4E (0.48) KMT2AKAT6AFABP4ACLYAKR1C3
SCHEMBL17599402 0.81 BRD4 (0.52) KMT2ABRD4FABP4FABP5ACLY
SCHEMBL17599312 0.81 KEAP1 (0.61) KMT2AMCL1KDM4E
SCHEMBL17599353 0.81 ACLY (0.58) KMT2AACLYMCL1PTK2BKDM4E
SCHEMBL17599317 0.80 FABP4 (0.52) KMT2AKAT6AFABP4FABP5ACLY

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2998294-A1 Naphthyl sulfonamide phenyl derivatives as KEAP-1 modulators for the treatment of diabetes, obesity, dyslipidemia and related disorders SANOFI (FR) 2016-03-23 EP disclosed
EP-2998294-A1 Naphthyl sulfonamide phenyl derivatives as KEAP-1 modulators for the treatment of diabetes, obesity, dyslipidemia and related disorders SANOFI (FR) 2016-03-23 EP disclosed